Wang Ruoyu, Li Heming, Guo Xuefen, Wang Zhe, Liang Shanshan, Dang Chengxue
Department of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, P.R. China.
Oncol Res. 2016;24(4):225-31. doi: 10.3727/096504016X14648701447931.
Recurrence and distant metastasis are the most common cause of therapeutic failure in nasopharyngeal carcinoma (NPC) patients. Insulin-like growth factor I (IGF-I) can induce epithelial-to-mesenchymal transition (EMT) in many epithelial tumors; however, whether IGF-I can enhance NPC metastasis by EMT and the mechanisms remain unclear. Herein, we have identified that IGF-I could induce EMT and enhance migration ability in NPC cell lines. Furthermore, both Src inhibitor and microRNA-30a (miR-30a) inhibitor reversed IGF-I-induced EMT, suggesting the involvement of an IGF-IR-Src-miR-30a-E-cadherin pathway in IGF-I-induced EMT in NPC cell lines. Overall, the results of the present study may provide more useful information regarding the mechanisms of the IGF-IR signaling pathway in the regulation of NPC metastasis. Both Src kinase and miR-30a can be potential biomarkers for selecting high risk of metastasis in NPC patients.
复发和远处转移是鼻咽癌(NPC)患者治疗失败的最常见原因。胰岛素样生长因子I(IGF-I)可在许多上皮性肿瘤中诱导上皮-间质转化(EMT);然而,IGF-I是否能通过EMT增强NPC转移及其机制仍不清楚。在此,我们已确定IGF-I可诱导NPC细胞系发生EMT并增强其迁移能力。此外,Src抑制剂和微小RNA-30a(miR-30a)抑制剂均可逆转IGF-I诱导的EMT,提示IGF-IR-Src-miR-30a-E-钙黏蛋白途径参与了NPC细胞系中IGF-I诱导的EMT。总体而言,本研究结果可能为IGF-IR信号通路调控NPC转移的机制提供更多有用信息。Src激酶和miR-30a均可作为选择NPC患者高转移风险的潜在生物标志物。